METLL3 activity promotes tumorigenesis in AML by enhancing BCL2 and PTEN translation50, whereas in glioblastoma stem cells, it suppresses growth and self‐renewal by reducing expression of ADAM1945. The gene discussed is PTEN; the disease is acute myeloid leukemia.